ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667472 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667472; 2) Community: the network communities that were significantly associated with the response to NSC 667472; 3) Molecule: the relationships between components within communities and NSC 667472; 4) MDR: the compounds that were significantly associated with the NSC 667472.

NSC Compound Enrichment Correlation
NSC 244404 Null 0.0348927754043159 0.11849545
NSC 300289 Pinafide 0.0348927754043159 0.18485648
NSC 303861 L-Cysteine analog 0.0348927754043159 0.47346145
NSC 339137 PHYSALOLACTONE 0.0348927754043159 0.37217291
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0348927754043159 0.23750617
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0348927754043159 0.29793191
NSC 359239 Antibiotic X-14766A 0.0348927754043159 -0.0016249813
NSC 39215 Null 0.0348927754043159 0.41670122
NSC 604976 Verrucarin A, 7'-deoxo-2'-deoxy-2',3'-epoxy-8',9',10',11'- tetrahydro-4',8-dihydroxy-7'-(1-hydroxyethyl)- 0.0348927754043159 0.13719413
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0348927754043159 0.40853519
Total:138  Current:99    [First] [Prev] [Next] [Last]